References
- Watson RE, Griffiths CE. Pathogenic aspects of cutaneous photo-aging. J Cosmet Dermatol. 2005;12(4):230–36.
- Hantash BM, Bedi VP, Kapadia B, Rahman Z, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Laser Surg Med. 2007;39(2):96–107.
- Prignano F, Campolmi P, Bonan P, Ricceri F, et al. Fractional CO2 laser: a novel therapeutic device upon pohtobiomodulation of tissue remodeling and cytokine pathway of tissue repair. Dermatol Ther. 2009;22(supple 1):S8–15.
- Helbig D, Bodendorf MO, Grunewald S, Kendler M, et al. Immunohistochemical investigation of wound healing in respinse to fractional photothermolysis. J Biomed Opt. 2009;14(6):064044.
- Hantash BM, Bedi VP, Chan KF, Zachary CB. Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39(2):87–95.
- Fang F, Cheng B, Wang DJ, Zhao Y. Cliniacal study on isotretinoin associated with fractional ultrapulse CO2 laser on stage = II, III rosacrea. Chin J Aesthetic Med. 2013;22(18):1864–66.
- Hua ZX, Shi J, Lin H. Clinical observation on joint therapeutic effect of Nd: yAGlaser and vitamin A acid cream on facial seborrheic keratosis. Chin J Laser Med Surg. 2016;25(4):204–08.
- Bryce GF, Bogdan NJ, Brown CC. Retinoic acids promote the repair of the dermal damage and the effacement of wrinkles in the UVB-irradiated hairless mouse. J Invest Dermatol. 1988;91(2):175–80.
- Weiss JS, Ellis CN, Headington JT, Voorhees JJ. Topical tretinoin in the treatment of aging skin. J Am Acad Dermatol. 1988;19(1 pt 2):169–75.
- Trelles MA, Mordon S, Velez M, Urdiales F, et al. Results of fractional ablative facial skin resurfacing with the erbium: yttrium-aluminium-garnet laser 1 week and 2 months after one single treatment in 30 patients. Lasers Med Sci. 2009;24(2):186–94.
- Talwar HS, Griffiths CE, Fisher GJ, Hamitton TA, et al. Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol. 1995;105(2):285–90.
- Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, et al. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. 2010;391(1):316–21.
- Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10(2):126–39.
- Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, Liebhaber SA, Pasquinelli AE, Shiekhattar R. MicroRNA silencing through RISC recruitment of eIF6. Nature. 2007;447(7146):823–28.
- Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642–55.
- Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 2010;62(6):1733–43.
- Luna C, Li G, Qiu J, Epstein DL, et al. Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells. Invest 0phthalmol Vis Sci. 2011;52(6):3567–72.
- Runyan CE, Schnaper HW, Poncelet AC. The phosphatidylinositol 3 kinase/Akt pathway enhance Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta. J Biol Chem. 2004;279(4):2632–39.